Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative Oral Pregabalin for Post Operative Pain in Inguinal Hernia Repair
NCT01450345Phase 3
Key facts
- Status
- Unknown
- Start
- Sep 2009
- Primary completion
- Dec 2011
- Countries
- 1
- Sponsor
- Universiti Malaya
- Modality
- Small Molecules
- Drugs
- pregabalin
- Conditions
- postoperative pain
01
Overview
Phase 3 trial of pregabalin in postoperative pain, sponsored by Universiti Malaya. Primary endpoint: Analgesic efficacy for post operative pain at 3 days. Status: unknown.
02
Design
1 armPregabalin Group
150 mg of oral Pregabalin 1 to 2 hours prior to induction
03
Who it enrols
Patients with clinical diagnosis of inguinal hernia undergoing daycare operation, ASA I-II. Excludes ASA > II, allergy to gabapentin/pregabalin, recurrent hernia repair, prior analgesia, liver/renal failure, and pregnancy.
04
Endpoints
Primary
Analgesic efficacy for post operative pain
Secondary
Opioid Sparing
Side effect of medication
Beyond the preview
Go deeper on NCT01450345.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01450345.